Latest Global Markets News

Scott Technology has locked in NZ$20 million worth of new Materials Handling & Logistics contracts across North America and Europe, reinforcing its Destination 2030 growth strategy and building on strong FY26 momentum.

Image Resources NL’s CEO Patrick Mutz will resign at the end of August 2026, with Chair Winston Lee stepping in as Executive Chair during the leadership transition. The company continues to operate its Atlas project while exploring innovative synthetic rutile processing.

NeuroScientific Biopharmaceuticals (ASX:NSB) has locked in a key FDA Pre-IND meeting for late August, advancing its Phase 2 trial plans for StemSmart™ targeting refractory Crohn’s disease in the US and Australia.

Japan Australia Fluorite Associates has received a $3 million funding tranche under the $7.4 million IPCM grant, supporting the ongoing Definitive Feasibility Study for the Speewah Fluorite Project in Western Australia.

Sprintex has inked a co-development deal with Jiangsu Bosiwei to supply its 30kW MVR compressors for a major retrofit at Hebei Yufeng Group, marking its strategic entry into China’s booming industrial vapor compression market.

Blue Star Helium has delivered its third helium trailer from the Pinon Canyon Plant, signalling steady progress toward full production capacity. A fourth trailer is currently being filled as the company pursues further plant optimisation and commercialisation of CO2 byproduct.

PM Capital Global Opportunities Fund Limited delivered a 41.5% jump in profit after tax to $238 million for FY26 and raised its fully franked dividend guidance to 16 cents for FY27, reflecting strong portfolio returns and robust earnings reserves.

EV Resources has secured its first binding five-year ore supply agreement with Chinantla, underpinning its Proof-of-Concept antimony processing campaign at Tecomatlán and advancing its regional hub strategy.

Acrux Limited spotlighted its Female Testosterone Metered Dose Transdermal System (MDTS) at the Bioshares Biotech Summit, revealing positive Phase II data and outlining a clear regulatory and commercial roadmap targeting Hypoactive Sexual Desire Disorder (HSDD) in women.

Dimerix CEO Dr Nina Webster detailed the company’s geographic and product diversification at the Bioshares Summit, spotlighting the commercial potential of DMX-200 and the newly acquired Phase 2 asset DMX-652 targeting acute kidney injury.

Pinnacle Investment Management delivered a 31.5% jump in net profit after tax to $176.7 million for FY26, boosted by full ownership of Pacific Asset Management and strong inflows across retail, institutional, and international channels.

Element 25 has locked in a binding take-or-pay offtake agreement with OM Materials for 100% of manganese concentrate from its Butcherbird Expansion, underpinning project financing and targeting commissioning in early 2027.